Electrophysiological effects of CI-980, a tubulin binding agent, on guinea-pig papillary muscles

British Journal of Pharmacology

Volumn 120, Issue 2, 1997, Pages 187-192

  Pérez, Onésima ^a   Valenzuela, Carmen ^a   Delpón, Eva ^a   Tamargo, Juan ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Action potential; CI 980; Tubulin binding agents; Use dependent block; V(max); Ventricular muscle

Indexed keywords

ANTIARRHYTHMIC AGENT; ISOPRENALINE; MIVOBULIN ISETHIONATE; POTASSIUM ION; SODIUM CHANNEL BLOCKING AGENT; TUBULIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DEPOLARIZATION; ELECTROPHYSIOLOGY; FEMALE; GUINEA PIG; HEART PAPILLARY MUSCLE; HEART RIGHT VENTRICLE; MALE; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; REPOLARIZATION;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARBAMATES; FEMALE; GUINEA PIGS; MALE; PAPILLARY MUSCLES; PYRAZINES; PYRIDINES; SODIUM CHANNEL BLOCKERS;

EID: 0031015897     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700878     Document Type: Article

References (37)

1. CAMPBELL, T. (1983a). Importance of physico-chemical properties in determining the kinetics of the effects of class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle. Br. J. Pharmacol., 80, 33-40.
2. CAMPBELL, T. (1983b). Kinetics of onset of rate-dependent effects of class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle and provide a theorectical basis for their subclassification. Cardiovasc. Res., 17, 344-352.
3. + channel activity. Am. J. Physiol., 261, C882-C888.
4. + current in rabbit ventricular myocytes. Cardiovasc. Drugs Ther., 7, 599-604.
5. CHEVALIER, P., KUZNETSOV, V., ROBINSON, R.B. & ROSEN, M.R. (1994). Tubulin binding agent CI-980 has positive inotropic and local anesthetic actions. J. Cardiovasc. Pharmacol., 23, 944-951.
6. COURTNEY, K.R. (1987). Quantitative structure-activity relations based on use-dependent block and repriming kinetics in myocardium. J. Moll. Cell. Cardiol., 19, 319-330.
7. + current in guinea-pig ventricular myocytes. Voltage-independent and time-dependent block of the slowly activating component. Circ. Res., 76, 223-235.
8. DELPON, E., VALENZUELA, C. & TAMARGO, J. (1989). Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscles. Br. J. Pharmacol., 96, 970-976.
9. DELPON, E., VALENZUELA, C. & TAMARGO, J. (1991). Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres. Br. J. Pharmacol., 103, 1411-1416.
10. FOZARD, H.A. & HANCK, D.A. (1992). Sodium channels. In The Heart and the Cardiovascular System. ed. Fozzard H.A., Haber, E., Jennings, R.B. & Katz, A.M. pp. 1091-1119, New York: Raven Press.
11. GRANT, A., STARMER, C. & STRAUSS, H. (1984). Antiarrhythmic drug action. Blockade of the inward sodium current. Circ. Res., 55, 427-439.
12. max in guinea-pig ventricular myocardium. Circ. Res., 50, 210-217.
13. HONDEGHEM, L. (1987). Antiarrhythmic agents: modulated receptor applications. Circulation, 75, 514-520.
14. HONDEGHEM, L. & KATZUNG, B. (1984). Antiarrhythmic agents: The modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Ann. Rev. Pharmacol. Toxicol., 24, 387-423.
15. HONDEGHEM, L. & SYNDERS, D.J. (1990). Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use-dependence. Circulation, 81, 886-890.
16. INES, C., LEYNADIER, D., BARASOAIN, I., PEYROT, V., GARCIA, P., BRIAND, C., TENER, G.A. & TEMPLE, C. (1994). Inhibition of microtubules and cell cycle arrest by a new 1-Deaza-7,8-dihydropterine antitumor drug, CI 980, and its chiral isomer NSC 613863. Cancer Res., 54, 75-84.
17. max of action potential in single ventricular myocytes. J. Mol. Cell. Cardiol., 22, 1-12.
18. KODAMA, I., SUZUKI, R., MARUYAMA, K. & TOYAMA, J. (1995). Electrophysiological effects of SD-3212, a new antiarrhythmic agent with vasodilating action, on guinea pig ventricular cells. Br. J. Pharmacol., 114, 503-509.
19. LAMPIDIS, T.J., KOLONIAS, D., SAVARAJ, N. & RUBIN, R.W. (1992). Cardiostimulatory and antiarrhythmic activity of tubulin-binding agent. Proc. Natl. Acad. Sci. U.S.A., 89, 1256-1260.
20. LEOPOLD, W.R., ELLIOT, W.L., PRYSBRANOWSKY, S.A. & WAND, R.E. (1993). In vivo evaluation of the potential for therapeutic synergy between CI 980 and standard chemotherapeutic agents. Proc. Am. Assoc. Cancer Res., 34, 296.
21. max of the slow responses and Ca-current availability in whole-cell clamped guinea-pig heart. Pflügers Arch., 410, 15-22.
22. MORGANROTH, J. (1993). Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms. Am. J. Cardiol., 72, 10B-13B.
23. PEREZ, O., VALENZUELA, C., DELPON, E. & TAMAGRO, J. (1994). Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscles. Br. J. Pharmacol., 111, 717-723.
24. REUTER, H. (1984). Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature, 301, 569-574.
25. RODEN, D. (1993). Current status of class III antiarrhythmic drug therapy. Am. J. Cardiol., 72, 44B-49B.
26. SANCHEZ-CHAPULA, J. (1985). Electrophysiological interactions between quinidine-lidocaine and quinidine-phenytoin in guinea-pig papillary muscle. Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 369-375.
27. SCHIFF, P.B., FANT, J. & HORWITZ, S.B. (1979). Promotion of microtubule assembly in vivo by taxol. Nature, 277, 665-667.
28. SCHIFF, P.B. & HORWITZ, S.B. (1980). Taxol stabilized microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. U.S.A., 77, 1561-1565.
29. Na in cardiac Purkinje fibres. Circ. Res., 63, 386-398.
30. SOROTA, S. & BOYDEN, P.A. (1991). Electrophysiology of the atrial myocardium. In Electrophysiology and Pharmacology of the Heart. ed. Dangman K.H. & Miura D.S. pp. 109-139. New York: Marcel Dekker.
31. TAMARGO, J., VALENZUELA, C. & DELPON, E. (1989). Modulated receptor hypothesis: selectivity and interactions of antiarrhythmic drugs. News Physiol. Sci., 4, 88-90.
32. TAMARGO, J., VALENZUELA, C. & DELPON, E. (1992). New insights into the pharmacology of sodium channel blockers. Eur. Heart J., 13(suppl F), 2-13.
33. max block induced by 5-hydroxypropafenone in guinea-pig ventricular muscles. J. Cardiovasc. Pharmacol., 12, 423-431.
34. VAUGHAN WILLIAMS, E.M. (1984). A classification of antiarrhythmic actions assessed after a decade of new drugs. J. Clin. Pharmacol., 24, 129-147.
35. WALLENSTEIN, S., ZUCKER, S. & FLEISS, J. (1990). Some statistical methods useful in circulation research. Circ. Res., 47, 1-9.
36. WAUD, W.R., LEOPOLD, W.R., ELLIOT, W.L., DYKES, D.J., LASTER, W.R. Jr., TEMPLE, C.G. Jr., HARRISON, S.D. Jr. & GRISWOLD, D.P. Jr. (1990). Antitumor activity of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7-ylcarbamate, 2-hydroxyethanesulfonate hydrate (NSC 370147) against selected tumor systems in culture and in mice. Cancer Res., 50, 3239-3244.
37. WOOSLEY, R. (1991). Antiarrhythmic drugs. Ann. Rev. Pharmacol., 31, 427-455.